{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:46:33Z","timestamp":1761540393485},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[1999,1,29]],"date-time":"1999-01-29T00:00:00Z","timestamp":917568000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[1999,2]]},"DOI":"10.1038\/sj.bjc.6690136","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T14:02:07Z","timestamp":1032271327000},"page":"850-857","source":"Crossref","is-referenced-by-count":18,"title":["Analysis of the interaction of monoclonal antibodies with surface IgM on neoplastic B-cells"],"prefix":"10.1038","volume":"79","author":[{"given":"M S","family":"Cragg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R R","family":"French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J","family":"Glennie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1999,1,29]]},"reference":[{"key":"BF6690136_CR1","first-page":"3015","volume":"53","author":"MA Bonardi","year":"1993","unstructured":"Bonardi, M. A., French, R. R., Amlot, P., Gromo, G., Modena, D. & Glennie, M. J. (1993). Delivery of saporin to human B-cell lymphoma using bispecific antibody targeting via CD22 but not CD19, CD37 or immunoglobulin results in efficient killing. Cancer Res 53: 3015\u20133021.","journal-title":"Cancer Res"},{"key":"BF6690136_CR2","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1084\/jem.155.5.1523","volume":"155","author":"AL De Franco","year":"1982","unstructured":"De Franco, A. L., Raveche, E. S., Asofsky, R. & Paul, W. E. (1982). Frequency of lymphocytes b responsive to anti-immunoglobulin. J Exp Med 155: 1523\u20131536.","journal-title":"J Exp Med"},{"key":"BF6690136_CR3","doi-asserted-by":"crossref","first-page":"981","DOI":"10.4049\/jimmunol.138.3.981","volume":"138","author":"TJ Elliot","year":"1987","unstructured":"Elliot, T. J., Glennie, M. J., McBride, H. M. & Stevenson, G. T. (1987). Analysis of the interaction of antibodies with immunoglobulin idiotype of neoplastic B lymphocytes; implications for immunotherapy. J Immunol 138: 981\u2013988.","journal-title":"J Immunol"},{"key":"BF6690136_CR4","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.4049\/jimmunol.151.11.5955","volume":"151","author":"J George","year":"1993","unstructured":"George, J., Penner, S. J., Weber, J., Berry, J. & Caflin, J. L. (1993). Influence of membrane Ig receptor density and affinity on B cell signaling by antigen. J Immunol 151: 5955\u20135965.","journal-title":"J Immunol"},{"key":"BF6690136_CR5","first-page":"225","volume-title":"Tumour Immunobiology, a Practical Approach","author":"MJ Glennie","year":"1993","unstructured":"Glennie, M. J., Tutt, A. L. & Greenman, J. (1993). Preparation of multispecific F (ab\u2032)2 and F(ab\u2032)3 antibody derivatives. In Tumour Immunobiology, a Practical Approach, Rees RC, Reynolds CW (eds), pp. 225\u2013244, Oxford University Press: Oxford"},{"key":"BF6690136_CR6","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1073\/pnas.88.8.3436","volume":"88","author":"MR Gold","year":"1991","unstructured":"Gold, M. R., Matsuuchi, L., Kelly, R. B. & De Franco, A. L. (1991). Tyrosine phosphorylation of components of the B-cell antigen receptors following receptor crosslinking. Proc Natl Acad Sci USA 88: 3436\u20133440.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6690136_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1006\/cimm.1997.1205","volume":"182","author":"G Grafton","year":"1997","unstructured":"Grafton, G., Goodall, M., Gregory, C. D. & Gordon, J. (1997). Mechanisms of antigen receptor-dependent apoptosis of human B lymphoma cells probed with a panel of 27 monclonal antibodies. Cell Immunol 182: 45\u201356.","journal-title":"Cell Immunol"},{"key":"BF6690136_CR8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/349612a0","volume":"349","author":"CD Gregory","year":"1991","unstructured":"Gregory, C. D., Dive, C., Henderson, S., Smith, C. A. & Williams, G. T. (1991). Activation of EBV latent genes protects human B cells from death by apoptosis. Nature 349: 612\u2013614.","journal-title":"Nature"},{"key":"BF6690136_CR9","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1099\/0022-1317-71-7-1481","volume":"71","author":"CD Gregory","year":"1990","unstructured":"Gregory, C. D., Rowe, M. & Rickinson, A. B. (1990). Different EBV-B cell interactions in phenotypically distinct clones of a Burkitt\u2019s lymphoma cell line. J Gen Virol 71: 1481\u20131495.","journal-title":"J Gen Virol"},{"key":"BF6690136_CR10","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/eji.1830200810","volume":"20","author":"J Hasbold","year":"1990","unstructured":"Hasbold, J. & Klaus, G. G. B. (1990). Anti-immunoglobulin antibodies induce apoptosis in immature B-cell lymphomas. Eur J Immunol 20: 1685\u20131690.","journal-title":"Eur J Immunol"},{"key":"BF6690136_CR11","first-page":"125","volume":"2","author":"R Marches","year":"1995","unstructured":"Marches, R., Racila, E., Tucker, T. F., Picker, L., Mongini, P., Hsueh, R., Vitetta, E. S., Scheuermann, R. H. & Uhr, J. W. (1995). Tumour dormancy and cell signalling \u2013 III: role of hypercrosslinking of IgM and CD40 on the induction of cell cycle arrest and apoptosis in B lymphoma cells. Therap Immunol 2: 125\u2013136.","journal-title":"Therap Immunol"},{"key":"BF6690136_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","volume":"139","author":"I Nicoletti","year":"1991","unstructured":"Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F. & Riccardi, C. (1991). A rapid and simple method for measuring thymocyte apoptosis by propridium iodide staining and flow cytometry. J Immunol Methods 139: 271\u2013279.","journal-title":"J Immunol Methods"},{"key":"BF6690136_CR13","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1084\/jem.181.4.1539","volume":"181","author":"E Racila","year":"1995","unstructured":"Racila, E., Schuermann, R. H., Picker, L. J., Yefenof, E., Tucker, T., Chang, W., Marches, R., Street, N. E., Vitetta, E. S. & Uhr, J. W. (1995). Tumor dormancy and signalling, II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice. J Exp Med 181: 1539\u20131550.","journal-title":"J Exp Med"},{"key":"BF6690136_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1084\/jem.168.1.247","volume":"168","author":"SM Rudich","year":"1988","unstructured":"Rudich, S. M., Roux, K. H., Winchester, R. J. & Mongini, P. K. A. (1988). Anti-IgM B cell mediated signaling \u2013 molecular analysis of ligand binding requisites for human B cell clonal expansion and tolerance. J Exp Med 168: 247\u2013266.","journal-title":"J Exp Med"},{"key":"BF6690136_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev.cb.07.110191.001353","volume":"7","author":"BM Sefton","year":"1991","unstructured":"Sefton, B. M. & Campbell, M. A. (1991). The role of tyrosine phosphorylation in lymphocyte activation. Ann Rev Cell Biol 7: 257\u2013274.","journal-title":"Ann Rev Cell Biol"},{"key":"BF6690136_CR16","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1182\/blood.V91.5.1644","volume":"91","author":"D Shan","year":"1998","unstructured":"Shan, D. Ledbetter, J. A. & Press, O. W. (1998). Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies. Blood 91: 1644\u20131652.","journal-title":"Blood"},{"key":"BF6690136_CR17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4049\/jimmunol.147.1.60","volume":"147","author":"AL Tutt","year":"1991","unstructured":"Tutt, A. L., Stevenson, G. T. & Glennie, M. J. (1991). Trispecific F(ab)3 derivatives that use cooperative signalling via the TCR\/CD3 complex and CD2 to activate and redirect resting cytotoxic T cells. J Immunol 147: 60\u201369.","journal-title":"J Immunol"},{"key":"BF6690136_CR18","doi-asserted-by":"crossref","unstructured":"Tutt, A. L., French, R. R., Illidge, T. M., Honeychurch, J., McBride, H., Penfold, C., Fearon, D. T., Parkhouse, M. E., Klaus, G. G. B. & Glennie, M. J. (1998). Monoclonal antibody therapy of B-cell lymphoma: signaling activity on tumour cells appears more important than recruitment of effectors. J Immunol (in press),","DOI":"10.4049\/jimmunol.161.6.3176"},{"key":"BF6690136_CR19","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1046\/j.1365-2249.1997.4201436.x","volume":"110","author":"Van Kooten","year":"1997","unstructured":"Van Kooten, Galiber, L., Seon, B. K., Garrone, P., Liu, Y-J & Banchereau, J. (1997). Cross-linking of antigen receptor via Ig-\u03b2 (B29, CD79b) can induce both positive and negative signals in CD40 activated human B cells. Clin Exp Immunol 110: 509\u2013515.","journal-title":"Clin Exp Immunol"},{"key":"BF6690136_CR20","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1182\/blood.V83.4.899.899","volume":"83","author":"WMJ Vuist","year":"1994","unstructured":"Vuist, W. M. J., Levy, R. & Maloney, D. G. (1994). Lymphoma regression induced by monoclonal anti-idiotype antibodies correlates with their ability to induce Ig signal transduction and is not prevented by tumour expression of high levels of bcl-2 protein. Blood 83: 899\u2013906.","journal-title":"Blood"},{"key":"BF6690136_CR21","first-page":"191","volume":"2","author":"I Zhang","year":"1995","unstructured":"Zhang, I., French, R. R., Chan, H. T. C., Cragg, M. S., Power, M. J. D. & Glennie, M. J. (1995). The development of anti-CD79 monoclonal antibodies for treatment of B-cell neoplastic disease. Therap Immunol 2: 191\u2013202.","journal-title":"Therap Immunol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6690136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690136","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:50:40Z","timestamp":1684414240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6690136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1,29]]},"references-count":21,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["BF6690136"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6690136","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,1,29]]}}}